title: Phospholamban gene dosage effects in chemically permeabilized mouse cardiac muscle.
authors.affiliation: Department of Pharmacology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
authors.forename: R T
authors.initials: RT
authors.lastname: Wiedmann
authors.forename: B S
authors.initials: BS
authors.lastname: Pan
authors.forename: E G
authors.initials: EG
authors.lastname: Kranias
authors.forename: S
authors.initials: S
authors.lastname: Motzel
authors.forename: R G
authors.initials: RG
authors.lastname: Johnson
mesh_terms: D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism*; D018628:Gene Dosage; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006352:Heart Ventricles; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009200:Myocardial Contraction / Q000187:drug effects / Q000502:physiology*; D000099211:Phospholamban
chemical_list: D002110:Caffeine; D002118:Calcium; D002135:Calcium-Binding Proteins; D000099211:Phospholamban